Screener
Aura Biosciences, Inc. AURA Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216808
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 118,504 | 149,739 |
| Restricted cash and deposits | 768 | 768 |
| Right-of-use assets - operating lease | 15,416 | 15,828 |
| Other long-term assets | 517 | 471 |
| Property and equipment, net | 2,472 | 2,624 |
| Total Assets | $137,677 | $169,430 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: |
Item 1. Financial Statements.
FAQ
- What is Aura Biosciences, Inc.'s deferred tax assets and other non-current assets?
- Aura Biosciences, Inc. (AURA) reported deferred tax assets and other non-current assets of $517K in Q1 2026.
- What is the long-term trend for Aura Biosciences, Inc.'s deferred tax assets and other non-current assets?
- Over 3 years (2022 to 2025), Aura Biosciences, Inc.'s deferred tax assets and other non-current assets has grown at a 3.6% compound annual growth rate (CAGR), from $423K to $471K.
Ask your AI about Aura Biosciences, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude